[Federal Register Volume 65, Number 110 (Wednesday, June 7, 2000)]
[Notices]
[Page 36154]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-14342]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Recombinant DNA Advisory Committee; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: June 28-29, 2000.
    Time: June 28-9 a.m. to 5 p.m.; June 29-8:30 a.m. to 5 p.m.
    Agenda: The agenda will include a discussion on novel human gene 
transfer protocol(s), DHHS Initiatives for Human Subjects 
Protections, continued deliberation on issues involving serious 
adverse events, review of the findings and recommendations from the 
Advisory Committee to the Director Working Group on Gene Transfer 
Studies, discussion of data management activities related to human 
gene transfer clinical trials, other matters to be considered by the 
Committee. Additional information is also available at the Officer 
of Biotechnology Activities' web site: http://www.nih.gov/od/oba/ on 
the Internet.
    Place: National Institutes of Health, Building 31, Conference 
Room 10, 9000 Rockville Pike, Bethesda, MD 20892.
    Contact Person: Amy P. Patterson, Director and Acting Executive 
Secretary, Officer of Biotechnology Activities, National Institutes 
of Health, MSC 7010, 6000 Executive Boulevard, Suite 302, Bethesda, 
MD 20892-7010, 301-496-9838.

    OMB's ``Mandatory Information Requirements for Federal 
Assistance Program Announcements'' (45 FR 39592, June 11, 1980) 
requires a statement concerning the official government programs 
contained in the Catalog of Federal Domestic Assistance. Normally 
NIH lists in its announcements the number and title of affected 
individual programs for the guidance of the public. Because the 
guidance in this notice covers virtually every NIH and Federal 
research program in which DNA recombinant molecule techniques could 
be used, it has been determined not to be cost effective or in the 
public interest to attempt to list these programs. Such a list would 
likely require several additional pages. In addition, NIH could not 
be certain that every Federal program would be included as many 
Federal agencies, as well as private organizations, both national 
and international, have elected to follow the NIH Guidelines. In 
lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.

    Dated: May 31, 2000
LaVerne Stringfield,
Director, Officer of Federal Advisory Committee Policy.
[FR Doc. 00-14342 Filed 6-6-00; 8:45 am]
BILLING CODE 4140-01-M